You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
6 December 2019
Germany’s Stada is acquiring the pharmaceutical and consumer healthcare business of Ukrainian company Biopharma, including its probiotic products, for an undisclosed sum.
5 November 2019
Stada Arzneimittel is acquiring Takeda’s OTC portfolio in Russia and the Commonwealth of Independent States (CIS) in a deal worth USD660 million. The deal comes a day after the German company announced it was purchasing Czech consumer healthcare firm Walmark.
4 November 2019
Stada Arzneimittel is boosting its consumer healthcare presence in Europe by acquiring Czech firm Walmark from private-equity firm Mid Europa Partners.
9 October 2019
The US dietary supplement industry wants rapid action on cannabidiol (CBD) products, Probi has revised its 2019 sales forecast and Thornton & Ross is expanding its capacity.
19 August 2019
A new product and a recent acquisition are expected to boost sales by Stada's Branded Products division in the second half of 2019.
25 June 2019
Germany's Stada has appointed RB's Eelco Ockers as executive vice president for its home market with effect from 15 September 2019.
21 June 2019
Stada has recruited Teva's Salvatore Butti as general manager of its Italian business with effect from 1 September 2019.
10 June 2019
Stada Arzneimittel is acquiring a portfolio of OTC brands, including Oilatum and Savlon Antiseptic Cream, from GlaxoSmithKline Consumer Healthcare for an undisclosed sum.
23 April 2019
Roger Scarlett-Smith is taking up a permanent position at Stada Arzneimittel following six months as interim managing director of the company's Thornton & Ross business in the UK.
22 March 2019
Stada Arzneimittel is seeking more acquisitions and cooperations, according to chief executive officer Peter Goldschmidt, and is interested in acquiring both products and entire companies.